Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Alvey

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Social Security Bulletin|November 1, 1979
Mortality reporting in SSA linked data: preliminary resultsW Alvey, F Aziz
Clinical Pharmacology in Drug Development|April 30, 2016
The effect of mild and moderate hepatic impairment on the pharmacokinetics of tofacitinib, an orally active Janus kinase inhibitorNervin Lawendy, Manisha Lamba, Gary Chan, et al.
International Journal of Clinical Pharmacology and Therapeutics|January 30, 2013
Bioequivalence assessment of a pregabalin capsule and oral solution in fasted healthy volunteers: a randomized, crossover studyHoward N Bockbrader, Christine W Alvey, Brian W Corrigan, et al.
Clinical Pharmacology in Drug Development|May 4, 2016
Evaluation of the Effect of Tofacitinib on the Pharmacokinetics of Oral Contraceptive Steroids in Healthy Female VolunteersSujatha Menon, Richard Riese, Ronnie Wang, et al.
Journal of Clinical Pharmacology|March 20, 1998
Meta-analysis of steady-state pharmacokinetics of troglitazone and its metabolitesC M Loi, C W Alvey, E J Randinitis, et al.
Clinical Pharmacology in Drug Development|May 4, 2016
Single- and multiple-dose pharmacokinetics of tofacitinib in healthy Chinese volunteersSriram Krishnaswami, Tao Wang, Yi Yuan, et al.
Journal of Clinical Pharmacology|September 3, 1999
Steady-state pharmacokinetics and dose proportionality of troglitazone and its metabolitesC M Loi, C W Alvey, A B Vassos, et al.
Journal of Clinical Pharmacology|March 18, 2003
Pharmacokinetics of pregabalin in subjects with various degrees of renal functionEdward J Randinitis, Edward L Posvar, Christine W Alvey, et al.
Epilepsia|November 8, 2014
Safety, tolerability, and pharmacokinetics of pregabalin in children with refractory partial seizures: a phase 1, randomized controlled studyDonald Mann, Jing Liu, Marci L Chew, et al.
Clinical Drug Investigation|August 1, 2014
Pregabalin controlled-release pharmacokinetics in healthy volunteers: analysis of four multiple-dose randomized clinical pharmacology studiesMarci L Chew, Christine W Alvey, Anna Plotka, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Social Security Bulletin|November 1, 1979
Mortality reporting in SSA linked data: preliminary resultsW Alvey, F Aziz
Clinical Pharmacology in Drug Development|April 30, 2016
The effect of mild and moderate hepatic impairment on the pharmacokinetics of tofacitinib, an orally active Janus kinase inhibitorNervin Lawendy, Manisha Lamba, Gary Chan, et al.
International Journal of Clinical Pharmacology and Therapeutics|January 30, 2013
Bioequivalence assessment of a pregabalin capsule and oral solution in fasted healthy volunteers: a randomized, crossover studyHoward N Bockbrader, Christine W Alvey, Brian W Corrigan, et al.
Clinical Pharmacology in Drug Development|May 4, 2016
Evaluation of the Effect of Tofacitinib on the Pharmacokinetics of Oral Contraceptive Steroids in Healthy Female VolunteersSujatha Menon, Richard Riese, Ronnie Wang, et al.
Journal of Clinical Pharmacology|March 20, 1998
Meta-analysis of steady-state pharmacokinetics of troglitazone and its metabolitesC M Loi, C W Alvey, E J Randinitis, et al.
Clinical Pharmacology in Drug Development|May 4, 2016
Single- and multiple-dose pharmacokinetics of tofacitinib in healthy Chinese volunteersSriram Krishnaswami, Tao Wang, Yi Yuan, et al.
Journal of Clinical Pharmacology|September 3, 1999
Steady-state pharmacokinetics and dose proportionality of troglitazone and its metabolitesC M Loi, C W Alvey, A B Vassos, et al.
Journal of Clinical Pharmacology|March 18, 2003
Pharmacokinetics of pregabalin in subjects with various degrees of renal functionEdward J Randinitis, Edward L Posvar, Christine W Alvey, et al.
Epilepsia|November 8, 2014
Safety, tolerability, and pharmacokinetics of pregabalin in children with refractory partial seizures: a phase 1, randomized controlled studyDonald Mann, Jing Liu, Marci L Chew, et al.
Clinical Drug Investigation|August 1, 2014
Pregabalin controlled-release pharmacokinetics in healthy volunteers: analysis of four multiple-dose randomized clinical pharmacology studiesMarci L Chew, Christine W Alvey, Anna Plotka, et al.
Pageof 2